CARM
Carisma Therapeutics
CARM
CARM
Delisted
CARM was delisted on the 10th of October, 2025.
45 hedge funds and large institutions have $32.3M invested in Carisma Therapeutics in 2020 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 17 increasing their positions, 8 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
13% more funds holding
Funds holding: 40 → 45 (+5)
0.13% more ownership
Funds ownership: 0.85% → 0.98% (+0.13%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Holders
45
Holding in Top 10
1
Calls
$650K
Puts
$55K
Top Buyers
| 1 | +$1.82M | |
| 2 | +$1.03M | |
| 3 | +$978K | |
| 4 |
Qube Research & Technologies (QRT)
London,
United Kingdom
|
+$767K |
| 5 |
SSA
Schonfeld Strategic Advisors
New York
|
+$571K |
Top Sellers
| 1 | -$616K | |
| 2 | -$130K | |
| 3 | -$119K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$48K |
| 5 |
UBS Group
Zurich,
Switzerland
|
-$41.1K |